7-(3-Chlorophenylamino)-1-cyclopropyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (2) was prepared and fully characterized by NMR, IR, and MS. Compound 2 exhibited good antibacterial activity against gram-positive standard and resistant strains.
Introduction
To date, fluoroquinolones represent successful synthetic antibacterial agents [1] [2] [3] [4] [5] . However, increased prescribing has led to the recent emergence of fluoroquinolone-resistant bacteria which has necessitated the search for newer drugs with efficacy against resistant strains [6, 7] . The present work aims at the synthesis of a new fluoroquinolone derivative (2) and screening of its activity.
Results and Discussion
An earlier study carried out by our team [4] revealed that substitution of lipophilic groups such as aniline at C-7 of 8-nitrofluoroquinolone (1) produced noticeable increase in gram-positive activity, especially against resistant strains with significant loss of gram-negative activity [4] . This research aims at further investigation of halogenated aniline derivatives exemplified by compound 2. Synthon 1 involved introducing an electron-withdrawing nitro group at C-8 to facilitate coupling of the chloro-
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aniline [4] . Although compound 2 was prepared by direct coupling of 7-chloro-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (1b) with a 2 molar excess of 3-chloroaniline in DMF/pyridine (7:3 V/V), the yield was very low after chromatographic separation from many side products. Alternatively, the chloroaniline was reacted with the correspondent ester (1a) to produce the target acid 2 in satisfactory yield upon hydrolysis of the ester intermediate (Scheme 1).
Scheme 1. Synthesis of target compound 2.
Cl The in vitro antibacterial activity of 2 was evaluated against standard and resistant isolates of grampositive Staphylococcus aureus and gram-negative Escherichia coli bacteria, using broth dilution method. Compound 2 revealed excellent antimicrobial activity against standard S. aureus strains (ATCC6538) with minimum inhibitory concentrations (MIC) of 0.88 µg/mL. Interestingly, it showed good activity against resistant isolates of S. aureus gram-positive bacteria with MIC value of 7.0 µg/mL. These data are comparable to ciprofloxacin reference which showed MIC values of 2.9 µg/mL and 1.4 µg/mL, respectively, against both gram-positive strains.
These findings are in correlation with literature findings that more lipophilic quinolones can better penetrate the lipophilic cell membrane of gram-positive bacteria [8, 9] .
Experimental
Two molar equivalents of 3-chloroaniline (0.36 g) were gradually added to a solution of ethyl 7-chloro-1-cyclopropyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (1a) (0.5 g) in 10 mL of DMSO and a few drops of pyridine. The mixture was heated at 70-80 °C under anhydrous conditions. The reaction mixture was left to crystallize, then filtered and the product was left to dry in a dark place. The resulting solid was recrystallized from methanol/chloroform (3x) to give fairly pure ester intermediate (0.15 g, 24%) . The intermediate was then hydrolyzed upon dissolving the solid in ethanol and adding conc. HCl (10 mL). The mixture was heated at 70-80 °C for 5 h, then compound 2 was collected by filtration and dried to give a yellow solid (0.13 g, 93% 
